Mettl7a alleviated bone loss in osteoporosis mice by targeting the O-GlcNAcylation of Bsp via m6A methylation
Stem Cells Translational Medicine · 25.06.2025 · 14 (7)
DOI: 10.1093/stcltm/szaf024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 25.06.2025. Verfasst von Yantong Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Signaling and Stem Cells Therapy, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical U…. Hauptthemen laut MEDLINE: Methyltransferases, Osteoporosis, Adenosine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, CAMS Innovation Fund for Medical Sciences, Innovation Research Team Project of Beijing Stomatological Hospital.
Abstract (Originalsprache)
Postmenopausal osteoporosis, a prevalent metabolic bone disease, elevates susceptibility to fragility fractures while imposing substantial healthcare costs and public health challenges. The profound interplay between BMSCs and surrounding extracellular matrix (ECM) proteins, which are highly rich in O-GlcNAcylation, play pivotal roles in the process of osteoporosis. M6A methylation plays a crucial regulatory role in the development of osteoporosis, while the crosstalk between m6A methylation and ECM O-GlcNAcylation remains mechanistically undefined. Here we found Mettl7a overexpression improved the impaired osteogenic capability of OVX-mBMSCs in vitro. Conditional knockout of Mettl7a in the mesenchyme (Prx1-cre;Mettl7af/f) accelerated bone loss of OVX mice. Mechanistically, Mettl7a promoted mBMSCs osteogenic differentiation by targeting the O-GlcNAcylation of Bsp, an ECM protein. Mettl7a regulated the expression and O-GlcNAcylation of Bsp through m6A methylation of Oga. We further demonstrated that Mettl7a-AAV treatment alleviated bone loss phenotype in osteoporosis mice via the O-GlcNAcylation of Bsp. Collectively, our findings reveal novel mechanistic intersections between ECM protein O-GlcNAcylation and m6A methylation, advancing the understanding of osteoporotic regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Signaling and Stem Cells Therapy, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Beijing 100050, China.
- Department of General Dentistry and Integrated Emergency Dental Care, Capital Medical University School of Stomatology, Beijing, China.
- Beijing Laboratory of Oral Health, Capital Medical University School, Beijing, 100069, China.
- Research Unit of Tooth Development and Regeneration, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Yantong Wang
Förderung
- National Key Research and Development Program
- CAMS Innovation Fund for Medical Sciences
- Innovation Research Team Project of Beijing Stomatological Hospital
- Capital Medical University
Zitieren
APA
Wang, Y., Cao, Y., & Fan, Z. (2025). Mettl7a alleviated bone loss in osteoporosis mice by targeting the O-GlcNAcylation of Bsp via m6A methylation. Stem Cells Translational Medicine, 14(7). https://doi.org/10.1093/stcltm/szaf024
Vancouver
Wang Y, Cao Y, Fan Z. Mettl7a alleviated bone loss in osteoporosis mice by targeting the O-GlcNAcylation of Bsp via m6A methylation. Stem Cells Translational Medicine. 2025;14(7). doi:10.1093/stcltm/szaf024
BibTeX
@article{Wang2025,
author = {Wang, Yantong and Cao, Yangyang and Fan, Zhipeng},
title = {Mettl7a alleviated bone loss in osteoporosis mice by targeting the O-GlcNAcylation of Bsp via m6A methylation},
journal = {Stem Cells Translational Medicine},
year = {2025},
volume = {14},
number = {7},
doi = {10.1093/stcltm/szaf024}
}
EUVIMED